Products And Services
Products And Services
Products and services
Products and services
Indication：For the treatment of minor, moderate or severe symptoms of Alzheimer’s disease.
Strength：5mg, 10mg
Package：cellophane/aluminum/polyethylene pharmaceutical laminate film package, 7 tablets/blister x 1 blister/carton, 7 tablets/blister x 2 blisters/carton
Validity：24 months
Approval number：5mg: National Medicine Standard H20010723
10mg: National Medicine Standard H20204034
- First in the country to pass the consistency evaluation of generic drugs.
- This product is the first drug approved by the FDA for the treatment of minor to severe Alzheimer's disease.
- It is a highly selective, reversible, long-acting cholinesterase inhibitor.
- A large amount of evidence-based proof shows that donepezil can improve patients' cognitive ability and memory impairment
- Minor adverse reaction, better safety.
- Once daily, easy to dose.
- Firstly launched in China market.
微信公众号